190 related articles for article (PubMed ID: 27894091)
1. Preclinical study of cinobufagin as a promising anti-colorectal cancer agent.
Lu XS; Qiao YB; Li Y; Yang B; Chen MB; Xing CG
Oncotarget; 2017 Jan; 8(1):988-998. PubMed ID: 27894091
[TBL] [Abstract][Full Text] [Related]
2. Endoplasmic reticulum stress activation mediates Ginseng Rg3-induced anti-gallbladder cancer cell activity.
Wu K; Li N; Sun H; Xu T; Jin F; Nie J
Biochem Biophys Res Commun; 2015 Oct; 466(3):369-75. PubMed ID: 26361144
[TBL] [Abstract][Full Text] [Related]
3. Aqueous Oldenlandia diffusa extracts inhibits colorectal cancer cells via activating AMP-activated protein kinase signalings.
Lu PH; Chen MB; Ji C; Li WT; Wei MX; Wu MH
Oncotarget; 2016 Jul; 7(29):45889-45900. PubMed ID: 27322552
[TBL] [Abstract][Full Text] [Related]
4. Sestrin 2 suppresses cells proliferation through AMPK/mTORC1 pathway activation in colorectal cancer.
Wei JL; Fang M; Fu ZX; Zhang SR; Guo JB; Wang R; Lv ZB; Xiong YF
Oncotarget; 2017 Jul; 8(30):49318-49328. PubMed ID: 28525387
[TBL] [Abstract][Full Text] [Related]
5. AT7867 Inhibits Human Colorectal Cancer Cells via AKT-Dependent and AKT-Independent Mechanisms.
Zhang S; Deng Z; Yao C; Huang P; Zhang Y; Cao S; Li X
PLoS One; 2017; 12(1):e0169585. PubMed ID: 28081222
[TBL] [Abstract][Full Text] [Related]
6. Bufotalin-induced apoptosis in osteoblastoma cells is associated with endoplasmic reticulum stress activation.
Zhu YR; Xu Y; Fang JF; Zhou F; Deng XW; Zhang YQ
Biochem Biophys Res Commun; 2014 Aug; 451(1):112-8. PubMed ID: 25068992
[TBL] [Abstract][Full Text] [Related]
7. Cinobufagin induces apoptosis of osteosarcoma cells through inactivation of Notch signaling.
Cao Y; Yu L; Dai G; Zhang S; Zhang Z; Gao T; Guo W
Eur J Pharmacol; 2017 Jan; 794():77-84. PubMed ID: 27845066
[TBL] [Abstract][Full Text] [Related]
8. Cinobufagin exerts anti-proliferative and pro-apoptotic effects through the modulation ROS-mediated MAPKs signaling pathway.
Baek SH; Kim C; Lee JH; Nam D; Lee J; Lee SG; Chung WS; Jang HJ; Kim SH; Ahn KS
Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):265-73. PubMed ID: 25982794
[TBL] [Abstract][Full Text] [Related]
9. Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells.
Zhijun H; Shusheng W; Han M; Jianping L; Li-Sen Q; Dechun L
Tumour Biol; 2016 Aug; 37(8):10257-67. PubMed ID: 26831668
[TBL] [Abstract][Full Text] [Related]
10. Pre-clinical characterization of PKC412, a multi-kinase inhibitor, against colorectal cancer cells.
Li JP; Huang ZJ; Lu XS; Zhou YC; Shao Y; He XP; Chen SR; Wang DD; Qin LS; Sun WH
Oncotarget; 2016 Nov; 7(47):77815-77824. PubMed ID: 27780925
[TBL] [Abstract][Full Text] [Related]
11. Endoplasmic reticulum stress triggered by Soyasapogenol B promotes apoptosis and autophagy in colorectal cancer.
Wang L; Yun L; Wang X; Sha L; Wang L; Sui Y; Zhang H
Life Sci; 2019 Feb; 218():16-24. PubMed ID: 30553871
[TBL] [Abstract][Full Text] [Related]
12. Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid.
Borrelli F; Pagano E; Romano B; Panzera S; Maiello F; Coppola D; De Petrocellis L; Buono L; Orlando P; Izzo AA
Carcinogenesis; 2014 Dec; 35(12):2787-97. PubMed ID: 25269802
[TBL] [Abstract][Full Text] [Related]
13. RKI-1447 suppresses colorectal carcinoma cell growth via disrupting cellular bioenergetics and mitochondrial dynamics.
Li L; Chen Q; Yu Y; Chen H; Lu M; Huang Y; Li P; Chang H
J Cell Physiol; 2020 Jan; 235(1):254-266. PubMed ID: 31237697
[TBL] [Abstract][Full Text] [Related]
14. RAPTOR promotes colorectal cancer proliferation by inducing mTORC1 and upregulating ribosome assembly factor URB1.
Wang T; Zhang WS; Wang ZX; Wu ZW; Du BB; Li LY; Chen YF; Yang XF; Hao XY; Guo TK
Cancer Med; 2020 Feb; 9(4):1529-1543. PubMed ID: 31886628
[TBL] [Abstract][Full Text] [Related]
15. The synthetic flavonoid WYC02-9 inhibits colorectal cancer cell growth through ROS-mediated activation of MAPK14 pathway.
Chen YJ; Chen HP; Cheng YJ; Lin YH; Liu KW; Chen YJ; Hou MF; Wu YC; Lee YC; Yuan SS
Life Sci; 2013 Jun; 92(22):1081-92. PubMed ID: 23624232
[TBL] [Abstract][Full Text] [Related]
16. Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer models.
Capasso A; Pitts TM; Klauck PJ; Bagby SM; Westbrook L; Kaplan J; Soleimani M; Spreafico A; Tentler JJ; Diamond JR; Arcaroli JJ; Messersmith WA; Eckhardt SG; Leong S
Anticancer Drugs; 2018 Oct; 29(9):827-838. PubMed ID: 30048249
[TBL] [Abstract][Full Text] [Related]
17. The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.
Lei S; Ding Y; Fu Y; Wu S; Xie X; Wang C; Liang H
PLoS One; 2017; 12(10):e0184501. PubMed ID: 29065135
[TBL] [Abstract][Full Text] [Related]
18. mTOR inhibition sensitizes ONC201-induced anti-colorectal cancer cell activity.
Jin ZZ; Wang W; Fang DL; Jin YJ
Biochem Biophys Res Commun; 2016 Sep; 478(4):1515-20. PubMed ID: 27565731
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
Yang S; Li W; Sun H; Wu B; Ji F; Sun T; Chang H; Shen P; Wang Y; Zhou D
BMC Cancer; 2015 Dec; 15():969. PubMed ID: 26674205
[TBL] [Abstract][Full Text] [Related]
20. Lupeol alters ER stress-signaling pathway by downregulating ABCG2 expression to induce Oxaliplatin-resistant LoVo colorectal cancer cell apoptosis.
Chen MC; Hsu HH; Chu YY; Cheng SF; Shen CY; Lin YJ; Chen RJ; Viswanadha VP; Lin YM; Huang CY
Environ Toxicol; 2018 May; 33(5):587-593. PubMed ID: 29436100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
